Cargando…
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
BACKGROUND: GPR40 is a G-protein coupled receptor regulating free fatty acid induced and also glucose induced insulin secretion. We generated neonatally-streptozotocin-treated female rats (n-STZ) and treated them with CNX-011-67, a GPR40 agonist to examine the role of GPR40 in modulation of glucose...
Autores principales: | Sunil, Venkategowda, Verma, Mahesh Kumar, Oommen, Anup M, Sadasivuni, Manojkumar, Singh, Jaideep, Vijayraghav, Dasarahalli N, Chandravanshi, Bhawna, Shetty, Jayalaxmi, Biswas, Sanghamitra, Dandu, Anilkumar, Moolemath, Yoganand, Venkataranganna, Marikunte V, Somesh, Baggavalli P, Jagannath, Madanahalli R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994293/ https://www.ncbi.nlm.nih.gov/pubmed/24666736 http://dx.doi.org/10.1186/2050-6511-15-19 |
Ejemplares similares
-
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats
por: Gowda, Nagesh, et al.
Publicado: (2013) -
A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro
por: Verma, Mahesh Kumar, et al.
Publicado: (2014) -
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits
por: Anil, Tharappel M, et al.
Publicado: (2014) -
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models
por: Sadasivuni, Manoj Kumar, et al.
Publicado: (2014) -
CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models
por: Anil, Tharappel M, et al.
Publicado: (2014)